Login to Your Account



Licensing Deals Rev Up

Chinese Government Support Hinders M&A Potential

By Shannon Ellis
Staff Writer

Wednesday, December 4, 2013

SHANGHAI – Few people are as well placed to understand the financing situation of China’s biomedicine sector than Mike Braun, managing partner for Deloitte’s Life Science & Health Financial Advisory Services in China.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription